Drug Type AAV based gene therapy |
Synonyms- |
Target |
Action modulators |
Mechanism DRG1 modulators(developmentally regulated GTP binding protein 1 modulators), DRG2 modulators(developmentally regulated GTP binding protein 2 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | Preclinical | United States | 15 Nov 2010 |